# Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure

> **NCT02730702** · — · UNKNOWN · sponsor: **American BioOptics, LLC** · enrollment: 600 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DEVICE:** LEBS - Low coherence enhanced backscattering

## Key facts

- **NCT ID:** NCT02730702
- **Lead sponsor:** American BioOptics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730702, "Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02730702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*